Preparation and Feasibility of Exams for Expected Studies

NCT ID: NCT05698810

Last Updated: 2025-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-20

Study Completion Date

2033-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Feasibility study: the examinations carried out as part of this protocol aim to carry out all the acquisitions and simulations of use, necessary for the development of the clinical research protocols to come to Clinatec (in particular, configuration of the equipment, dimension of the examination time and the size of the cohorts etc ...)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To ensure the feasibility of a clinical trial, it is necessary to test the parameters as well as the sequence of the different examination times offered to participants.

The expected results of this protocol are mainly the dimension of experimental paradigms and the optimization of the clinical management of subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers Parkinson's Disease Patients Para/Tetraplegic Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

volunteers
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers

tests

Group Type OTHER

CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability

Intervention Type OTHER

tests

CE marked Medical Device Magnetic Resonance Imaging (MRI) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroEncephaloGraphy (EEG) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroCardioGraphy (ECG) usability

Intervention Type OTHER

tests

Parkinson's Disease patients

tests

Group Type OTHER

CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability

Intervention Type OTHER

tests

CE marked Medical Device Magnetic Resonance Imaging (MRI) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroEncephaloGraphy (EEG) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroCardioGraphy (ECG) usability

Intervention Type OTHER

tests

Para/tetraplegic Patients

tests

Group Type OTHER

CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability

Intervention Type OTHER

tests

CE marked Medical Device Magnetic Resonance Imaging (MRI) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroEncephaloGraphy (EEG) usability

Intervention Type OTHER

tests

CE marked Medical Device ElectroCardioGraphy (ECG) usability

Intervention Type OTHER

tests

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability

tests

Intervention Type OTHER

CE marked Medical Device Magnetic Resonance Imaging (MRI) usability

tests

Intervention Type OTHER

CE marked Medical Device ElectroEncephaloGraphy (EEG) usability

tests

Intervention Type OTHER

CE marked Medical Device ElectroCardioGraphy (ECG) usability

tests

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ⩾ 18 years
* Affiliated to a social security scheme
* Free and informed consent signed

Exclusion Criteria

* Subject in a period of exclusion from another study.
* Subject deprived of liberty by a judicial or administrative decision, or major subject subject to a legal protection measure (guardianship, curatorship and safeguarding of justice) referred to in Articles 1121-6 to 1121-8 of the Public Health Code.
* Subject who would receive more than 4500 euros in compensation because of his participation in other research involving the human person in the 12 months preceding this study.
* Pregnant woman, parturient, nursing mother (Article 1121-5 of the Public Health Code)
* Subject not reachable urgently.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Commissariat A L'energie Atomique

OTHER_GOV

Sponsor Role collaborator

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinatec Cea/Chuga

Grenoble, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stéphan CHABARDES, MD, PhD

Role: primary

+33476767559

Caroline SANDRE-BALLESTER, PhD

Role: backup

0438782851

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC22.0130

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.